European Journal of Clinical Microbiology and Infectious Diseases

, Volume 11, Issue 2, pp 99–109

Fungal infections in cancer patients: An international autopsy survey

Authors

  • G. Bodey
    • M.D. Anderson Cancer Center
  • B. Bueltmann
    • University of Ulm
  • W. Duguid
    • Montreal General Hospital
  • D. Gibbs
    • Pfizer International, Inc.
  • H. Hanak
    • Hanusch Hospital
  • M. Hotchi
    • Shinshu University Hospital
  • G. Mall
    • University of Heidelberg
  • P. Martino
    • University La Sapienza
  • F. Meunier
    • EORTC
  • S. Milliken
    • Royal Marsden Hospital
  • S. Naoe
    • Toho University
  • M. Okudaira
    • Kitazato University
  • D. Scevola
    • University of Pavia
  • J. van't Wout
    • Leiden University
Article

DOI: 10.1007/BF01967060

Cite this article as:
Bodey, G., Bueltmann, B., Duguid, W. et al. Eur. J. Clin. Microbiol. Infect. Dis. (1992) 11: 99. doi:10.1007/BF01967060

Abstract

In an attempt to estimate the frequency of fungal infections among cancer patients, a survey of autopsy examinations was conducted in multiple institutions in Europe, Japan and Canada. Fungal infections were identified most often in leukemic patients and transplant recipients (25 % each). Fifty-eight percent of fungal infections were caused byCandida spp. and 30 % byAspergillus spp. There was considerable variability in the frequency of fungal infections in different countries. Nevertheless, this study clearly demonstrates that fungal infections represent a common complication in cancer patients, especially in patients with leukemia.

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1992